Abstract
The prevalence of colonization with toxigenic Clostridium difficile among patients with hematological malignancies and/or bone marrow transplant at admission to a 566-bed academic medical care center was 9.3%, and 13.3% of colonized patients developed symptomatic disease during hospitalization. This population may benefit from targeted C. difficile infection control interventions. Infect Control Hosp Epidemiol 2017;38:718-720.
MeSH terms
-
Adult
-
Aged
-
Antineoplastic Agents / therapeutic use
-
Bone Marrow Transplantation
-
Carrier State / diagnosis*
-
Carrier State / microbiology
-
Cephalosporins / therapeutic use
-
Clostridioides difficile*
-
Enterocolitis, Pseudomembranous / diagnosis*
-
Enterocolitis, Pseudomembranous / microbiology
-
Female
-
Hematologic Neoplasms / complications*
-
Hematologic Neoplasms / drug therapy
-
Humans
-
Male
-
Middle Aged
-
Patient Admission
-
Prevalence
-
Prospective Studies
-
Risk Factors
Substances
-
Antineoplastic Agents
-
Cephalosporins